Neural Effects of Continuous Intravenous Infusion of N,N-dimethyltryptamine (DMT)

Phase: PHASE1 | Sponsor: Jon Dean | Compound: DMT

Status

planned

Institution

Jon Dean

Start date

2026-09-01

End date

2029-09-01

Registry ID

NCT07693257

View trial record

Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.